High arterial blood oxygen tension leads to vasoconstriction of retinal vessels, possibly related to an interaction between reactive oxygen species and endothelium-derived vasoactive factors. Vitamin C is a potent antioxidant capable of reversing endothelial dysfunction due to increased oxidant stress. Vitamin C appears to have vasodilatory properties, but the underlying mechanisms are not well understood. In the present study we hypothesized that hyperoxic vasoconstriction of retinal vessels could be diminished by vitamin C. Ocular blood flow will be determined by non-invasive methods, including laser Doppler velocimetry and the Zeiss retinal vessel analyser.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Enrollment
12
Substance: Ascorbic acid (Mayrhofer) Manufacturer: Mayrhofer, Linz, Austria Dosage form: i.v. Dosage: 24mg/min over 64 min Dosage reference: Ting HH 1996
Substance: Physiologic saline solution 0.9% (placebo) Dosage form: i.v. Dosage: 24ml/min over 64 min
Substance: 100% oxygen (AGA, Vienna, Austria, gases for human use) Manufacturer: AGA, Vienna, Austria, gases for human use Dosage form: Inhalation through an oxygenmask over a period of 12 minutes two times per study day. Dosage reference: Strenn K 1997
Department of Clinical Pharmacology
Vienna, Vienna, Austria
Retinal arterial and venous diameter (Zeiss retinal vessel analyzer)
Time frame: in total 6 hours
Retinal blood flow velocity (laser Doppler velocimetry)
Time frame: in total 6 hours
Intraocular pressure (applanation tonometry)
Time frame: in total 10 minutes
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.